|Articles|November 6, 2015
Elevating the Patient Voice: Leveraging Patients' Expertise to Advance Drug Development
Author(s)DIA
Advertisement
A report on progress with PDUFA V commitments to hold patient-focused drug development meetings; and on how patient focus is being built into 21st Century Cures legislation and forthcoming PDUFA VI reauthorization.
This article appeared in the August 2015 issue of
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Amgen’s Tarlatamab Approved in China
2
Pharmaceutical Executive Daily: China Approves Amgen's Tarlatamab for Previously Treated Extensive-Stage Small Cell Lung Cancer
3
Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement
4
Shionogi Inc. Awarded $482 Million Contract with U.S. Government to Enhance National Preparedness for Drug-Resistant Bacterial Threats
5